As of 2025-03-20, the Relative Valuation of Iovance Biotherapeutics Inc (IOVA) is (19.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.56 USD, the upside of Iovance Biotherapeutics Inc based on Relative Valuation is -650.0%.
The range of the Relative Valuation is (19.71) - (27.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.4x - 27.3x | 17.8x |
| Forward P/E multiples | 16.3x - 23.9x | 16.7x |
| Fair Price | (19.71) - (27.13) | (19.58) |
| Upside | -653.5% - -862.0% | -650.0% |
| Date | P/E |
| 2025-03-18 | -3.15 |
| 2025-03-17 | -3.29 |
| 2025-03-14 | -3.16 |
| 2025-03-13 | -3.10 |
| 2025-03-12 | -3.37 |
| 2025-03-11 | -3.44 |
| 2025-03-10 | -3.29 |
| 2025-03-07 | -3.30 |
| 2025-03-06 | -3.30 |
| 2025-03-05 | -3.57 |
| 2025-03-04 | -3.45 |
| 2025-03-03 | -3.56 |
| 2025-02-28 | -3.73 |
| 2025-02-27 | -4.63 |
| 2025-02-26 | -4.71 |
| 2025-02-25 | -4.70 |
| 2025-02-24 | -4.89 |
| 2025-02-21 | -5.09 |
| 2025-02-20 | -4.94 |
| 2025-02-19 | -4.98 |
| 2025-02-18 | -4.90 |
| 2025-02-14 | -4.91 |
| 2025-02-13 | -4.70 |
| 2025-02-12 | -4.70 |
| 2025-02-11 | -4.66 |
| 2025-02-10 | -4.69 |
| 2025-02-07 | -5.01 |
| 2025-02-06 | -5.18 |
| 2025-02-05 | -5.37 |
| 2025-02-04 | -5.12 |
| 2025-02-03 | -4.97 |
| 2025-01-31 | -5.15 |
| 2025-01-30 | -5.47 |
| 2025-01-29 | -5.35 |
| 2025-01-28 | -5.45 |
| 2025-01-27 | -5.51 |
| 2025-01-24 | -5.51 |
| 2025-01-23 | -5.45 |
| 2025-01-22 | -5.28 |
| 2025-01-21 | -5.18 |
| 2025-01-17 | -5.21 |
| 2025-01-16 | -5.07 |
| 2025-01-15 | -5.21 |
| 2025-01-14 | -5.19 |
| 2025-01-13 | -5.09 |
| 2025-01-10 | -5.64 |
| 2025-01-08 | -6.32 |
| 2025-01-07 | -6.52 |
| 2025-01-06 | -6.59 |
| 2025-01-03 | -6.74 |